From clinical trial results to major policy change announcements, here we present an overview of the latest industry news from the biggest players in neuroscience and neurology
Jeffrey C. Hall, Michael Rosbash and Michael W. Young receive the award for their work on the molecular mechanisms controlling circadian rhythms.
The Lancet International Commission on Dementia Prevention, Intervention and Care has reported that more than one-third of global dementia cases may be preventable through addressing lifestyle factors that impact an individual’s risk.
Dr Paul Gallagher (Institute of Neurological Sciences, Glasgow, UK) provides an overview of these two recent papers by Jokubaitis and colleagues  and Cree and colleagues, which both assessed factors predictive of long-term disability outcomes in people with multiple sclerosis (MS).
Take a look at our infographic – we explore our current knowledge of the interactions between alcohol and epigenetic mechanisms, and take a look at the latest research and drug targets.